SummitTX Capital »

Kalvista Pharmaceuticals shares owned by SummitTX Capital

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by SummitTX Capital from 13F filings

Historical chart of SummitTX Capital investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by SummitTX Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by SummitTX Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.7M 144k 12.18

More positions owned by SummitTX Capital

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Cisco Systems (CSCO)
MKS Instruments (MKSI)
NVIDIA Corporation (NVDA)
Cyberark Software SHS (CYBR)
PPL Corporation (PPL)
Meritage Homes Corporation (MTH)
Toll Brothers (TOL)
Teradyne (TER)
Applied Materials (AMAT)
Griffon Corporation (GFF)
Owens Corning (OC)

View all positions for SummitTX Capital

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Tang Capital Management
Frazier Life Sciences Management
Suvretta Capital Management
Capital World Investors
BlackRock
Vanguard Group
Millennium Management
Woodline Partners
Goldman Sachs Group
Parkman Healthcare Partners
Caption Management
State Street Corporation
Silverarc Capital Management
Emerald Advisers

View all funds holding Kalvista Pharmaceuticals